Drug-induced eosinophilia.

Allergy Asthma Proc

Department of Allergy and Immunology, Allegheny Health Network, Pittsburgh, Pennsylvania.

Published: May 2018

Background: Drug reactions have been associated with increased blood eosinophil levels.

Objective: To review clinical characteristics, the diagnosis, and the management of drug-induced eosinophilia.

Methods: Pertinent articles were selected and reviewed in relation to a case presentation of drug-induced eosinophilia.

Results: A case of asymptomatic eosinophilia in the setting of acetylsalicylic acid (aspirin) use was presented, followed by discussion of the clinical characteristics, diagnosis, and management of drug-induced eosinophilia. Clinical pearls and pitfalls were reviewed for the practicing allergist, clinical immunologist, and fellow-in-training.

Conclusion: Drug-induced eosinophilia is a diagnosis of exclusion. Although most cases of drug-induced eosinophilia are asymptomatic, one study showed an increased rate of hypersensitivity reactions in patients with higher eosinophil counts and earlier onset of eosinophilia.

Download full-text PDF

Source
http://dx.doi.org/10.2500/aap.2018.39.4120DOI Listing

Publication Analysis

Top Keywords

drug-induced eosinophilia
16
clinical characteristics
8
characteristics diagnosis
8
diagnosis management
8
management drug-induced
8
drug-induced
6
eosinophilia
5
eosinophilia background
4
background drug
4
drug reactions
4

Similar Publications

Background: Sulfasalazine (SSZ) is commonly prescribed for the treatment of ulcerative colitis, rheumatoid arthritis, and ankylosing spondylitis. However, it can also trigger a severe drug reaction known as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) or Drug-Induced Hypersensitivity Syndrome (DIHS). This article aims to analyze the clinical characteristics of DRESS/DIHS induced by SSZ and provide evidence for clinical diagnosis, treatment, and prevention.

View Article and Find Full Text PDF

Vancomycin and linezolid: severe cutaneous adverse reactions to drugs.

Expert Opin Drug Saf

December 2024

Department of Pharmacy, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Background: Severe cutaneous adverse reactions (SCARs), including Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), and Acute Generalized Exanthematous Pustulosis (AGEP), pose significant therapeutic challenges. Vancomycin and linezolid have been linked to these life-threatening conditions, necessitating a better understanding of their associated risks.

Methods: We conducted a retrospective analysis using data from the FDA Adverse Event Reporting System (FAERS) database.

View Article and Find Full Text PDF

[A rare medical chameleon with fatal consequences].

Inn Med (Heidelb)

November 2024

Medizinische Klinik, Evangelisches Krankenhaus Düsseldorf, Kirchfeldstraße 40, 40217, Düsseldorf, Deutschland.

The following case describes the relapsing and ultimately fatal outcome of DRESS (drug reaction with eosinophilia and systemic symptoms) syndrome as an often misdiagnosed drug-induced hypersensitivity reaction. The disease was complicated by progressive worsening with involvement of multiple organs and profound agranulocytosis. The main goal of this article is to raise awareness of the syndrome and its potential severity.

View Article and Find Full Text PDF
Article Synopsis
  • - Severe cutaneous adverse reactions (SCARs) like AGEP, DRESS, SJS, and TEN are serious conditions associated with high mortality rates, and while corticosteroids are commonly used for treatment, their effectiveness is uncertain due to infection risks.
  • - Recent studies have introduced TNF-α inhibitors, which have shown promise in treating SCARs, with a report indicating that four patients (21-54 years old) treated with these inhibitors had successful recoveries without complications.
  • - The TNF-α inhibitors work by targeting the harmful immune response linked to SCARs, but more large-scale trials are needed to confirm their efficacy and ensure a safe approach to their use.
View Article and Find Full Text PDF

Background: Eosinophilic gastroenteritis is a rare disease characterized by eosinophilic infiltration into one or more layers of the gastrointestinal tract. It commonly affects children more than adults. The clinical features depend on the site of gut involvement, but the most common symptoms include abdominal pain and diarrhea.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!